Artwork

Innhold levert av CREST Bipolar Disorder Network. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av CREST Bipolar Disorder Network eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du fĂžlge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
GĂ„ frakoblet med Player FM -appen!

Psychedelics & Bipolar Disorder: Psilocybin, Ketamine & Treatment | Dr. Josh Woolley | EP. 18 🍄

1:04:31
 
Del
 

Manage episode 342741168 series 3400573
Innhold levert av CREST Bipolar Disorder Network. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av CREST Bipolar Disorder Network eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du fĂžlge prosessen skissert her https://no.player.fm/legal.

Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treatment.

Hosted by Dr. Erin Michalak.

Dr. Josh Woolley is currently the principal investigator and director of UCSF’s Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The lab’s mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. He’s also the director of the translational psychedelic research program at UCSF.

#talkBD gathers researchers, people with lived experience, healthcare providers, and top bipolar disorder experts from around the world to discuss and answer the most important questions about living with bipolar disorder. Learn more about the talkBD Bipolar Disorder Podcast and upcoming episodes at https://talkBD.live

  continue reading

41 episoder

Artwork
iconDel
 
Manage episode 342741168 series 3400573
Innhold levert av CREST Bipolar Disorder Network. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av CREST Bipolar Disorder Network eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du fĂžlge prosessen skissert her https://no.player.fm/legal.

Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treatment.

Hosted by Dr. Erin Michalak.

Dr. Josh Woolley is currently the principal investigator and director of UCSF’s Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The lab’s mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. He’s also the director of the translational psychedelic research program at UCSF.

#talkBD gathers researchers, people with lived experience, healthcare providers, and top bipolar disorder experts from around the world to discuss and answer the most important questions about living with bipolar disorder. Learn more about the talkBD Bipolar Disorder Podcast and upcoming episodes at https://talkBD.live

  continue reading

41 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for hÞykvalitets podcaster som du kan nyte nÄ. Det er den beste podcastappen og fungerer pÄ Android, iPhone og internett. Registrer deg for Ä synkronisere abonnement pÄ flere enheter.

 

Hurtigreferanseguide